New review highlights growing evidence that diabetes drug metformin can prevent long COVID

Multiple randomized clinical trials and analyses of electronic health records (EHRs) suggest that metformin, a widely available diabetes drug, may reduce the risk of developing long COVID when taken during or shortly after acute COVID-19…

Continue Reading


News Source: www.cidrap.umn.edu

Comments

Leave a Reply

Your email address will not be published. Required fields are marked *